Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Heliyon ; 8(3): e09045, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-35287328

RESUMO

The synthesized 3,3-di(indolyl)indolin-2-ones 1a-p showed desired higher α-glucosidase inhibitory activities and lower α-amylase inhibitory activities than standard drug acarbose. Particularly, compound 1i showed favorable higher α-glucosidase % inhibition of 67 ± 13 and lower α-amylase % inhibition of 51 ± 4 in comparison to acarbose with % inhibition activities of 19 ± 5 and 90 ± 2, respectively. Docking studies of selected 3,3-di(indolyl)indolin-2-ones revealed key interactions with the active sites of both α-glucosidase and α-amylase, further supporting the observed % inhibitory activities. Furthermore, the binding energies are consistent with the % inhibition values. The results suggest that 3,3-di(indolyl)indolin-2-ones may be developed as suitable Alpha Glucosidase Inhibitors (AGIs) and the lower α-amylase activities should be advantageous to reduce the side effects exhibited by commercial AGIs.

2.
Molecules ; 27(2)2022 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-35056850

RESUMO

In this study, we report on an orthogonal strategy for the precise synthesis of 3,3'-, 3,4'-, and 3,6'-phenylpropanoid sucrose esters (PSEs). The strategy relies on carefully selected protecting groups and deprotecting agents, taking into consideration the reactivity of the four free hydroxyl groups of the key starting material: di-isopropylidene sucrose 2. The synthetic strategy is general, and potentially applies to the preparation of many natural and unnatural PSEs, especially those substituted at 3-, 3'-, 4'- and 6'-positions of PSEs.

3.
Curr Med Chem ; 29(9): 1606-1621, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-34455958

RESUMO

INTRODUCTION: Feruloyl Sucrose Esters (FSEs) are a class of Phenylpropanoid Sucrose Esters (PSEs) widely distributed in plants. They were investigated as potential selective Alpha Glucosidase Inhibitors (AGIs) to eliminate the side effects associated with the current commercial AGIs. The latter effectively lowers blood glucose levels in diabetic patients but causes severe gastrointestinal side effects. METHODS: Systematic structure-activity relationship (SAR) studies using in silico, in vitro and in vivo experiments were used to accomplish this aim. FSEs were evaluated for their in vitro inhibition of starch and oligosaccharide digesting enzymes α-glucosidase and α- amylase followed by in silico docking studies to identify the binding modes. A lead candidate, FSE 12 was investigated in an STZ mouse model. RESULTS: All active FSEs showed desired higher % inhibition of α-glucosidase and desired lower inhibition of α -amylase in comparison to AGI gold standard acarbose. This suggests a greater selectivity of the FSEs towards α -glucosidase than α -amylase, which is proposed to eliminate the gastrointestinal side effects. From the in vitro studies, the position and number of the feruloyl substituents on the sucrose core, the aromatic 'OH' group, and the diisopropylidene bridges were key determinants of the % inhibition of α - glucosidase and α -amylase. In particular, the diisopropylidene bridges are critical for achieving inhibition selectivity. Molecular docking studies of the FSEs corroborates the in vitro results. The molecular docking studies further reveal that the presence of free aromatic 'OH' groups and the substitution at position 3 on the sucrose core are critical for the inhibition of both the enzymes. From the in vitro and molecular docking studies, FSE 12 was selected as a lead candidate for validation in vivo. The oral co-administration of FSE 12 with starch abrogated the increase in post-prandial glucose and significantly reduced blood glucose excursion in STZ-treated mice compared to control (starch only) mice. CONCLUSION: Our studies reveal the potential of FSEs as selective AGIs for the treatment of diabetes, with a hypothetical reduction of side effects associated with commercial AGIs.


Assuntos
Diabetes Mellitus , alfa-Glucosidases , Animais , Glicemia/metabolismo , Diabetes Mellitus/tratamento farmacológico , Ésteres/farmacologia , Ésteres/uso terapêutico , Inibidores de Glicosídeo Hidrolases/química , Inibidores de Glicosídeo Hidrolases/farmacologia , Humanos , Hipoglicemiantes/química , Hipoglicemiantes/farmacologia , Hipoglicemiantes/uso terapêutico , Camundongos , Simulação de Acoplamento Molecular , Amido/uso terapêutico , Sacarose/uso terapêutico , alfa-Amilases/química , alfa-Amilases/metabolismo , alfa-Glucosidases/metabolismo
4.
Molecules ; 26(2)2021 Jan 18.
Artigo em Inglês | MEDLINE | ID: mdl-33477457

RESUMO

Cinnamoyl sucrose esters (CSEs) were evaluated as AGIs and their enzyme inhibition activity and potency were compared with gold standard acarbose. The inhibition activity of the CSEs against α-glucosidase and α-amylase depended on their structure including the number of the cinnamoyl moieties, their position, and the presence or absence of the acetyl moieties. The inhibitory values of the CSEs 2-9 generally increases in the order of mono-cinnamoyl moieties < di-cinnamoyl ≤ tri-cinnamoyl < tetra-cinnamoyl. This trend was supported from both in vitro and in silico results. Both tetra-cinnamoyl CSEs 5 and 9 showed the highest α-glucosidase inhibitory activities of 77 ± 5%, 74 ± 9%, respectively, against acarbose at 27 ± 4%, and highest α-amylase inhibitory activities of 98 ± 2%, 99 ± 1%, respectively, against acarbose at 93 ± 2%. CSEs 3, 4, 6, 7, 8 showed desired higher inhibition of α-glucosidase than α-amylase suggesting potential for further development as AGIs with reduced side effects. Molecular docking studies on CSEs 5 and 9 attributed the high inhibition of these compounds to multiple π-π interactions and favorable projection of the cinnamoyl moieties (especially O-3 cinnamoyl) in the enzyme pockets. This work proposes CSEs as new AGIs with potentially reduced side effects.


Assuntos
Cinamatos/farmacologia , Diabetes Mellitus/tratamento farmacológico , Ésteres/química , Inibidores de Glicosídeo Hidrolases/farmacologia , Sacarose/química , alfa-Glucosidases/química , Animais , Cinamatos/química , Simulação por Computador , Inibidores de Glicosídeo Hidrolases/química , Humanos , Simulação de Acoplamento Molecular , alfa-Amilases/antagonistas & inibidores
5.
Stem Cells Int ; 2015: 270428, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26089912

RESUMO

The G9a histone methyltransferase inhibitor BIX01294 was examined for its ability to expand the cardiac capacity of bone marrow cells. Inhibition of G9a histone methyltransferase by gene specific knockdown or BIX01294 treatment was sufficient to induce expression of precardiac markers Mesp1 and brachyury in bone marrow cells. BIX01294 treatment also allowed bone marrow mesenchymal stem cells (MSCs) to express the cardiac transcription factors Nkx2.5, GATA4, and myocardin when subsequently exposed to the cardiogenic stimulating factor Wnt11. Incubation of BIX01294-treated MSCs with cardiac conditioned media provoked formation of phase bright cells that exhibited a morphology and molecular profile resembling similar cells that normally form from cultured atrial tissue. Subsequent aggregation and differentiation of BIX01294-induced, MSC-derived phase bright cells provoked their cardiomyogenesis. This latter outcome was indicated by their widespread expression of the primary sarcomeric proteins muscle α-actinin and titin. MSC-derived cultures that were not initially treated with BIX01294 exhibited neither a commensurate burst of phase bright cells nor stimulation of sarcomeric protein expression. Collectively, these data indicate that BIX01294 has utility as a pharmacological agent that could enhance the ability of an abundant and accessible stem cell population to regenerate new myocytes for cardiac repair.

6.
Chempluschem ; 80(8): 1279-1287, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31973292

RESUMO

Carbon nanotubes (CNTs) possess well-defined structural and chemical characteristics coupled with a large surface area that makes them ideal as sorbent materials for applications where adsorption processes are required. The adsorption properties of carboxylated derivatives of multiwalled carbon nanotubes (COOH-MWCNT) and singlewalled carbon nanotubes (COOH-SWCNT), together with their nonfunctionalized counterparts (MWCNT and SWCNT) for 48 common atmospheric volatile organic compounds (VOCs) were determined using thermal desorption-gas chromatography/mass spectrometry (TD-GCMS). The CNTs exhibited similar recoveries for many of the VOCs compared to the standard sorbent materials, Carbopack X and Tenax TA. However, VOCs with electron donor-acceptor (EDA) properties such as carbonyls, alkenes, and alcohols exhibited poorer recoveries on all CNTs compared to Carbopack X and Tenax TA. The poor recoveries of VOCs from the CNTs has important implications for the long term use and storage of CNTs, because it demonstrates that they will become progressively more contaminated with common atmospheric VOCs, therefore potentially affecting their surface-based properties.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...